iShares Biotechnology ETF Rating → The 7th Trillion Dollar Company? (From The Oxford Club) (Ad) Free IBB Stock Alerts $133.58 -2.09 (-1.54%) (As of 03:10 PM ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends iShares Biotechnology ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy2.56Holdings in IBB have an aggregate rating of Moderate Buy based on 678 analyst ratings issued in the past year covering 50 companies (84.7% of the portfolio).IBB Aggregate Price Target$157.0117.54% UpsideHigh Prediction$206.58Average Prediction$157.01Low Prediction$113.95Holdings in IBB have an aggregate price target of $157.01 and a range of $113.95 to $206.58 covering 50 companies (84.7% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy7 Buy rating(s)Moderate Buy33 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.10%AMGNAmgen$299.24-2.2%5 of 5 stars2.52$305.65 2.1%21Short Interest ↑Analyst Revision8.56%VRTXVertex Pharmaceuticals$447.25-2.1%4 of 5 stars2.50$432.18 -3.4%24Analyst Downgrade8.20%REGNRegeneron Pharmaceuticals$966.47-1.9%4 of 5 stars2.76$989.36 2.4%217.57%GILDGilead Sciences$63.89-2.7%5 of 5 stars2.35$83.69 31.0%175.37%MRNAModerna$150.56-9.6%3 of 5 stars2.24$126.46 -16.0%17Analyst RevisionGap Down3.98%IQVIQVIA$225.99-1.6%4 of 5 stars2.80$257.57 14.0%15Analyst Revision3.18%BIIBBiogen$217.26-0.3%5 of 5 stars2.65$288.46 32.8%26Short Interest ↑3.11%MTDMettler-Toledo International$1,454.06-1.7%4 of 5 stars2.14$1,257.14 -13.5%7Positive News2.07%BNTXBioNTech$93.68-3.4%1 of 5 stars2.20$111.70 19.2%10Short Interest ↓2.02%WATWaters$332.14-1.3%3 of 5 stars1.90$305.78 -7.9%101.85%ALNYAlnylam Pharmaceuticals$150.24+1.7%5 of 5 stars2.59$216.19 43.9%17Positive News1.79%ARGXargenx$365.92-0.3%3 of 5 stars2.71$524.68 43.4%21Short Interest ↓1.66%ILMNIllumina$104.70-1.7%5 of 5 stars2.30$164.65 57.3%20Short Interest ↑1.64%GMABGenmab A/S$27.95-0.2%3 of 5 stars2.38$48.50 73.5%13Short Interest ↑1.39%BMRNBioMarin Pharmaceutical$74.36-1.5%5 of 5 stars2.57$106.11 42.7%211.32%BGNEBeiGene$152.06-0.4%3 of 5 stars2.80$251.93 65.7%10Short Interest ↓Positive News1.32%NBIXNeurocrine Biosciences$140.72+0.9%4 of 5 stars2.79$148.96 5.9%25Analyst ForecastPositive News1.27%TECHBio-Techne$79.29-1.9%4 of 5 stars2.73$81.00 2.2%11Positive News1.27%INCYIncyte$57.07-0.4%5 of 5 stars2.44$73.69 29.1%18Short Interest ↓1.18%NTRANatera$109.10-0.4%1 of 5 stars3.00$98.47 -9.7%151.17%UTHRUnited Therapeutics$268.39-1.6%5 of 5 stars2.90$309.44 15.3%10Positive News1.11%SRPTSarepta Therapeutics$113.48-8.1%5 of 5 stars2.79$164.47 44.9%14Analyst ForecastGap DownHigh Trading Volume1.08%CRLCharles River Laboratories International$213.06-1.9%5 of 5 stars2.64$255.27 19.8%11Analyst DowngradePositive News0.94%MEDPMedpace$391.04+0.1%5 of 5 stars2.80$443.00 13.3%6Analyst ForecastPositive News0.84%RGENRepligen$156.20-1.2%4 of 5 stars2.89$197.75 26.6%9Positive News0.72%PCVXVaxcyte$68.71-0.1%1 of 5 stars3.00$78.50 14.2%4Positive News0.69%BRKRBruker$75.72-2.0%5 of 5 stars2.50$85.00 12.3%8Short Interest ↑0.64%LEGNLegend Biotech$41.16-0.6%3 of 5 stars3.00$81.10 97.0%11Analyst Revision0.62%ITCIIntra-Cellular Therapies$65.37-0.3%5 of 5 stars2.90$90.17 37.9%10Positive News0.62%ASNDAscendis Pharma A/S$127.59-2.2%1 of 5 stars2.88$176.88 38.6%8Short Interest ↓0.61%EXELExelixis$20.30-1.3%5 of 5 stars2.59$26.13 28.7%170.60%BPMCBlueprint Medicines$102.12-0.7%1 of 5 stars2.53$103.94 1.8%17Positive News0.58%CYTKCytokinetics$47.89-0.8%4 of 5 stars2.82$77.47 61.8%17Analyst ForecastAnalyst Revision0.56%HALOHalozyme Therapeutics$42.89-2.1%5 of 5 stars2.83$53.14 23.9%6Positive News0.53%RVMDRevolution Medicines$38.21+0.7%4 of 5 stars3.10$43.20 13.1%10Positive News0.53%ROIVRoivant Sciences$10.78-1.8%3 of 5 stars2.90$16.90 56.8%10Upcoming EarningsPositive News0.50%IONSIonis Pharmaceuticals$37.54+0.7%4 of 5 stars2.71$59.54 58.6%14Positive News0.44%CRSPCRISPR Therapeutics$54.55-1.2%3 of 5 stars2.35$73.57 34.9%17Short Interest ↑0.42%APLSApellis Pharmaceuticals$40.44-0.4%4 of 5 stars2.87$76.27 88.6%15Analyst Forecast0.39%ALKSAlkermes$23.91-0.5%5 of 5 stars2.50$36.78 53.8%10Analyst Revision0.39%KRYSKrystal Biotech$156.56-3.9%4 of 5 stars3.00$177.63 13.5%9Positive News0.37%MDGLMadrigal Pharmaceuticals$223.26-2.8%5 of 5 stars2.73$345.09 54.6%110.37%BBIOBridgeBio Pharma$27.42-1.9%5 of 5 stars2.91$47.67 73.8%12Analyst Forecast0.35%CRNXCrinetics Pharmaceuticals$46.84-1.3%4 of 5 stars2.92$60.92 30.1%120.34%INSMInsmed$46.03+109.2%3 of 5 stars3.00$44.71 -2.9%14Analyst ForecastShort Interest ↑News CoverageGap UpHigh Trading Volume0.31%RAREUltragenyx Pharmaceutical$39.16-2.9%4 of 5 stars2.92$87.85 124.3%12Positive News0.29%ARWRArrowhead Pharmaceuticals$23.62-5.1%4 of 5 stars2.78$51.00 115.9%90.29%AXSMAxsome Therapeutics$75.55+0.5%5 of 5 stars2.92$121.92 61.4%13Positive News0.27%XENEXenon Pharmaceuticals$38.55+0.5%3 of 5 stars3.00$59.11 53.3%9Positive News0.27%PTCTPTC Therapeutics$36.85-0.9%3 of 5 stars2.07$35.67 -3.2%14Analyst Forecast This page (NASDAQ:IBB) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe 7th Trillion Dollar Company?The Oxford ClubThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden replacement revealed?Paradigm Press[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesBiggest Prediction of My 50-Year Career on Wall StreetChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
